The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents

Oncogene

Volumn 19, Issue 31, 2000, Pages 3498-3507

  Gillet, R ^a   Grimber, G ^a   Bennoun, M ^a   Caron de Fromentel, C ^a   Briand, P ^a   Joulin, V ^a  

^a INSTITUT COCHIN   (France)

Author keywords

Apoptosis; DNA damage; Hepatocarcinoma; p53; Transgenic mice

Indexed keywords

DOXORUBICIN; PROTEIN P53; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; GENOTOXICITY; LIVER CARCINOGENESIS; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN VIRUS 40; TRANSGENIC MOUSE; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BINDING SITES; BODY WEIGHT; CELL LINE, TRANSFORMED; CROSSES, GENETIC; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DISEASE PROGRESSION; DNA; DNA DAMAGE; DOXORUBICIN; GAMMA RAYS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENOTYPE; HYPERPLASIA; LIVER; LIVER DISEASES; LIVER NEOPLASMS, EXPERIMENTAL; METHOTREXATE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; NUCLEAR PROTEINS; ORGAN SIZE; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; SIMIAN VIRUS 40; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

ANIMALIA; MURINAE; MUS MUSCULUS; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0034691677     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203671     Document Type: Article

References (60)

1. Albrechtsen N, Dornreiter I, Grosse F, Kim E, Wiesmüller L and Deppert W. (1999). Oncogene, 18, 7706-7717.
2. Allemand I, Anglo A, Jeantet AY, Cerutti I and May E. (1999). Oncogene, 18, 6521-6530.
3. Allemand I, Grimber G, Kornprobst M, Bennoun M, Molina T, Briand P and Joulin V. (1995). Oncogene, 11, 2583-2590.
4. Bellamy CO, Clarke AR, Wyllie AH and Harrison DJ. (1997a). FASEB J., 11, 591-599.
5. Bellamy CO, Prost S, Wyllie AH and Harrison DJ. (1997b). J. Pathol., 183, 177-181.
6. Bennoun M, Grimber G, Couton D, Seye A, Molina T, Briand P and Joulin V. (1998). Oncogene, 17, 1253-1259.
7. Blagosklonny MV and El Deiry WS. (1998). Int. J. Cancer, 75, 933-940.
8. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B. (1998). Science, 282, 1497-1501.
9. Conzen SD, Snay CA and Cole CN. (1997). J. Virol., 71, 4536-4543.
10. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH and Reid BJ. (1995). Science, 267, 1353-1356.
11. Demers GW, Foster SA, Halbert CL and Galloway DA. (1994). Proc. Natl. Acad. Sci. USA, 91, 4382-4386.
12. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CAJ, Butel JS and Bradley A. (1992). Nature, 356, 215-221.
13. Dubois N, Bennoun M, Allemand I, Molina T, Grimber G, Daudet MM, Abelanet R and Briand P. (1991). J. Hepatol., 13, 227-239.
14. Fan S, El Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace Jr AJ, Magrath I, Kohn KW and O'Connor PM. (1994). Cancer Res., 54, 5824-5830.
15. Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R and Prives C. (1992). Nature, 358, 83-86.
16. Fearon ER and Vogelstein B. (1990). Cell, 61, 759-767.
17. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB and Roth JA. (1994). Cancer Res., 54, 2287-2291.
18. Fukasawa K, Sakoulas G, Pollack RE and Chen S. (1991). Mol. Cell. Biol., 11, 3472-3483.
19. Ghebranious N and Sell S. (1998). Hepatology, 27, 967-973.
20. Ginsberg D, Mechta F, Yaniv M and Oren M. (1991). Proc. Natl. Acad. Sci. USA, 88, 9979-9983.
21. Godley LA, Kopp JB, Eckhaus M, Paglino JJ, Owens J and Varmus HE. (1996). Genes Dev., 10, 836-850.
22. Goto A, Kanda H, Ishikawa Y, Matsumoto S, Kawaguchi N, Machinami R, Kato Y and Kitagawa T. (1998). Jpn. J. Cancer Res., 89, 539-547.
23. Gudas JM, Nguyen H, Li T, Sadzewicz L, Robey R, Wosikowski K and Cowan KH. (1996). Carcinogenesis, 17, 1417-1427.
24. Gurnani M, Lipari P, Dell J, Shi B and Nielsen LL. (1999). Cancer Chemother. Pharmacol., 44, 143-151.
25. Hickman ES, Bates S and Vousden KH. (1997). J. Virol., 71, 3710-3718.
26. Jimenez GS, Khan SH, Stommel JM and Wahl GM. (1999). Oncogene, 18, 7656-7665.
27. Jones JM, Attardi L, Godley LA, Laucirica R, Medina D, Jacks T, Varmus HE and Donehower LA. (1997). Cell Growth Differ., 8, 829-838.
28. Ju JF, Banerjee D, Lenz HJ, Danenberg KD, Schmittgen TC, Spears CP, Schonthal AH, Manno DJ, Hochhauser D, Bertino JR and Danenberg PV. (1998). Clin. Cancer Res., 4, 1315-1322.
29. Jung YK and Yuan J. (1997). Oncogene, 14, 1207-1214.
30. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
31. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C and Vogelstein B. (1991). Science, 252, 1708-1711.
32. Khan SH and Wahl GM. (1998). Cancer Res., 58, 396-401.
33. Komarova EA, Chernov MV, Franks R, Wang K, Armin G, Zelnick CR, Chin DM, Bacus SS, Stark GR and Gudkov AV. (1997). EMBO J., 16, 1391-1400.
34. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. (1992). Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
35. La Baer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A and Harlow E. (1997). Genes Dev., 11, 847-862.
36. Lane DP. (1992). Nature, 358, 15-16.
37. Lanni JS and Jacks T. (1998). Mol. Cell. Biol., 18, 1055-1064.
38. Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T and Bernstein A. (1989). Mol. Cell. Biol., 9, 3982-3991.
39. Levine AJ. (1997). Cell, 88, 323-331.
40. Levine AJ, Momand J and Finlay CA. (1991). Nature, 351, 453-456.
41. Li B, Murphy KL, Laucirica R, Kittrell F, Medina D and Rosen JM. (1998). Oncogene, 16, 997-1007.
42. MacCallum DE, Hupp TR, Midgley CA, Stuart D, Campbell SJ, Harper A, Walsh FS, Wright EG, Balmain A, Lane DP and Hall PA. (1996). Oncogene, 13, 2575-2587.
43. Midgley CA, Owens B, Briscoe CV, Thomas DB, Lane DP and Hall PA. (1995). J. Cell Sci., 108, 1843-1848.
44. Momand J, Zambetti GP, Olson DC, George D and Levine AJ. (1992). Cell, 69, 1237-1245.
45. Nakamura T, Pichel JG, Williams-Simons L and Westphal H. (1995). Proc. Natl. Acad. Sci. USA, 92, 6142-6146.
46. Nielsen LL and Maneval DC. (1998). Cancer Gene Ther., 5, 52-63.
47. Notterman D, Young S, Wainger B and Levine AJ. (1998). Oncogene, 17, 2743-2751.
48. Piovesan B, Pennell N and Berinstein NL. (1998). Oncogene, 17, 2339-2350.
49. Procopio A, Strizzi L, Giuffrida A, Scarpa S, Giuliano M, Iezzi T, Mutti L and Modesti A. (1998). Monaldi. Arch. Chest. Dis., 53, 241-243.
50. Rouquet N, Allemand I, Molina T, Bennoun M, Briand P and Joulin V. (1995). Oncogene, 11, 1061-1067.
51. Seth P, Katayose D, Li Z, Kim M, Wersto R, Craig C, Shanmugam N, Ohri E, Mudahar B, Rakkar AN, Kodali P and Cowan K. (1997). Cancer Gene Ther., 4, 383-390.
52. Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ and Shenk T. (1992). Proc. Natl. Acad. Sci. USA, 89, 12028-12032.
53. Slebos RJ, Lee MH, Plunkett BS, Kessis TD, Williams BO, Jacks T, Hedrick L, Kastan MB and Cho KR. (1994). Proc. Natl. Acad. Sci. USA, 91, 5320-5324.
54. Song K, Li Z, Seth P, Cowan KH and Sinha BK. (1997). Oncol. Res., 9, 603-609.
55. Symonds H, Krall L, Remington L, Saenz Robles M, Lowe S, Jacks T and Van Dyke T. (1994). Cell, 78, 703-711.
56. Tremp GL, Duchange N, Branellec D, Cereghini S, Tailleux A, Berthou L, Fievet C, Touchet N, Schombert B, Fruchart JC, Zakin MM and Denèfle P. (1995). Gene, 156, 199-205.
57. Tsai S-C, Pasumarthi KBS, Pajak L, Franklin M, Patton B, Wang H, Henzel WJ, Stults JT and Field LJ. (2000). J. Biol. Chem., 275, 3239-3246.
58. Vogelstein B and Kinzler KW. (1992). Cell, 70, 523-526.
59. Wu H, Wade M, Krall L, Grisham J, Xiong Y and Van Dyke T. (1996). Genes Dev., 10, 245-260.
60. Zambetti GP, Bargonetti J, Walker K, Prives C and Levine AJ. (1992). Genes Dev., 6, 1143-1152.